CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

Leucovorin LV

Phase 2
AstraZeneca PLC (AZN)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
AZNPhase 2

Datopotamab deruxtecan (Dato-DXd) Phase 2 Est. Readout

Leucovorin LV
Q4 2027~Q
CT.gov
00%
Drug Information

Target Indication

Endometrial Cancer

Clinical Trial

NCT05489211

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.